# Allows a licensed pharmacist to order and administer certain tests

**Bill ID:** A6627BB
**Session:** 2023
**Sponsor:** John T. McDonald III
**Status:** In Assembly Committee

## Summary

Allows a licensed pharmacist to order and administer certain tests.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  6627--B
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  April 24, 2023
  ___________
 
 Introduced  by  M.  of  A.  McDONALD, SAYEGH, WALLACE, SEAWRIGHT, MEEKS,
  JONES, JENSEN, LUPARDO, STIRPE, BUTTENSCHON, LUNSFORD  --  Multi-Spon-
  sored by -- M. of A.  TAGUE -- read once and referred to the Committee
  on  Higher  Education  --  committee discharged, bill amended, ordered
  reprinted as amended and recommitted to said committee --  recommitted
  to  the Committee on Higher Education in accordance with Assembly Rule
  3, sec. 2 -- committee discharged, bill amended, ordered reprinted  as
  amended and recommitted to said committee
 
 AN  ACT  to  amend the education law, in relation to allowing a licensed
  pharmacist to order and administer certain tests; and to amend part  C
  of  chapter  57 of the laws of 2022 amending the public health law and
  the education law relating to allowing pharmacists to  direct  limited
  service  laboratories  and order and administer COVID-19 and influenza
  tests and modernizing nurse practitioners, in relation to  the  effec-
  tiveness thereof
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Subdivision 7 of section 6801  of  the  education  law,  as
 added  by  section  2  of  part  C of chapter 57 of the laws of 2022, is
 amended to read as follows:
  7. A licensed pharmacist is a qualified health care professional under
 section five hundred seventy-one  of  the  public  health  law  for  the
 purposes  of  directing  a  limited  service laboratory and ordering and
 administering COVID-19 [and],  influenza,  RESPIRATORY  SYNCYTIAL  VIRUS
 (RSV),  PHARYNGITIS  RESULTING  FROM  A GROUP A STREPTOCOCCAL INFECTION,
 HBA1C, HEPATITIS C, AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) tests author-
 ized by the Food and Drug Administration (FDA), subject  to  certificate
 of  waiver  requirements  established  pursuant  to the federal clinical
 laboratory improvement act of nineteen hundred eighty-eight.
  ยง 2. Section 8 of part C of chapter 57 of the laws  of  2022  amending
 the public health law and the education law relating to allowing pharma-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD02558-06-3
 A. 6627--B  2
 
 cists  to  direct  limited service laboratories and order and administer
 COVID-19 and influenza tests and  modernizing  nurse  practitioners,  is
 amended to read as follows:
  ยง  8.  This  act  shall take effect immediately and shall be deemed to
 have been in full force and effect on and after April 1, 2022; provided,
 however, that sections one, two, three, four, six and seven of this  act
 shall expire and be deemed repealed [two] FOUR years after it shall have
 become a law.
  ยง  3.  This act shall take effect immediately; provided, however, that
 the amendments to subdivision 7 of section 6801  of  the  education  law
 made  by  section  one  of  this act shall not affect the repeal of such
 subdivision and shall be deemed repealed therewith.